Proactive Strategies to Avoid Supply Delays to be Presented by Catalent at Outsourcing in Clinical Trials Virtual Conference
SOMERSET, N.J. – May 14, 2020 — Catalent, a global leader in clinical supply services, today announced that Stephanie Graham, Regional Manager, Clinical Supplies Management, will present at the upcoming conference, ‘Outsourcing in Clinical Trials 2020 – A Virtual Experience’, which takes place on May 27, 2020.
Ms. Graham’s presentation, at 11:30 a.m., titled “Proactive Strategies to Identify Clinical Supply Risks and Avoid Study Delays”, will discuss the types of sponsors and studies which may be at a greater risk of experiencing clinical supply challenges, and will illustrate how sponsors may be able to avoid costly study delays by identifying study characteristics that are most likely to indicate that potential issues lie ahead.
Ms. Graham has more than 13 years of experience in clinical supplies management, packaging and distribution, in addition to 13 years spent working in international shipping. Prior to joining Catalent in 2015, she held roles at Fisher Clinical Services, Shire Pharmaceuticals and Takeda.
Notes for Editors
ABOUT CATALENT CLINICAL SUPPLY SERVICES
Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries, Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.
ABOUT CATALENT
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,500 people, including over 2,400 scientists and technicians, at more than 40 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com